X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SANOFI INDIA TTK HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 19.1 33.5 57.0% View Chart
P/BV x 4.9 6.4 76.8% View Chart
Dividend Yield % 0.6 0.6 99.7%  

Financials

 TTK HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SANOFI INDIA
Dec-17
TTK HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6634,945 13.4%   
Low Rs3993,901 10.2%   
Sales per share (Unadj.) Rs535.61,081.8 49.5%  
Earnings per share (Unadj.) Rs15.9141.6 11.3%  
Cash flow per share (Unadj.) Rs20.0185.9 10.8%  
Dividends per share (Unadj.) Rs4.0033.00 12.1%  
Dividend yield (eoy) %0.80.7 100.9%  
Book value per share (Unadj.) Rs137.6868.8 15.8%  
Shares outstanding (eoy) m7.7723.03 33.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.1 24.3%   
Avg P/E ratio x33.331.2 106.6%  
P/CF ratio (eoy) x26.523.8 111.5%  
Price / Book Value ratio x3.95.1 75.8%  
Dividend payout %25.123.3 107.6%   
Avg Mkt Cap Rs m4,127101,862 4.1%   
No. of employees `0001.73.2 52.7%   
Total wages/salary Rs m6073,685 16.5%   
Avg. sales/employee Rs Th2,436.77,691.9 31.7%   
Avg. wages/employee Rs Th355.21,137.7 31.2%   
Avg. net profit/employee Rs Th72.51,006.5 7.2%   
INCOME DATA
Net Sales Rs m4,16224,914 16.7%  
Other income Rs m61807 7.6%   
Total revenues Rs m4,22325,721 16.4%   
Gross profit Rs m1975,372 3.7%  
Depreciation Rs m321,022 3.1%   
Interest Rs m3011 271.8%   
Profit before tax Rs m1975,146 3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,886 3.9%   
Profit after tax Rs m1243,260 3.8%  
Gross profit margin %4.721.6 22.0%  
Effective tax rate %37.036.6 101.0%   
Net profit margin %3.013.1 22.8%  
BALANCE SHEET DATA
Current assets Rs m1,62914,432 11.3%   
Current liabilities Rs m1,0586,010 17.6%   
Net working cap to sales %13.733.8 40.6%  
Current ratio x1.52.4 64.1%  
Inventory Days Days3061 48.9%  
Debtors Days Days3428 117.9%  
Net fixed assets Rs m5567,991 7.0%   
Share capital Rs m78230 33.7%   
"Free" reserves Rs m87819,778 4.4%   
Net worth Rs m1,06920,008 5.3%   
Long term debt Rs m1590-   
Total assets Rs m2,39927,770 8.6%  
Interest coverage x7.6468.8 1.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.9 193.3%   
Return on assets %6.411.8 54.4%  
Return on equity %11.616.3 71.1%  
Return on capital %18.525.8 71.6%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m336,306 0.5%   
Fx outflow Rs m635,257 1.2%   
Net fx Rs m-301,049 -2.9%   
CASH FLOW
From Operations Rs m1274,351 2.9%  
From Investments Rs m-146-787 18.6%  
From Financial Activity Rs m22-1,884 -1.2%  
Net Cashflow Rs m31,680 0.1%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 3.7 14.4 25.7%  
FIIs % 5.2 14.6 35.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 15,184 83.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  BIOCON   

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views on News

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Mar 22, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS